The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

A breakthrough HIV drug that only needs to be injected twice a year to offer near-total protection from the virus and ...

2:03 Marking 40 years since the first cases of AIDS reported in U.S. Moderna is beginning a trial of an mRNA vaccine for HIV, the company announced Thursday. First doses of the vaccine have been ...

While no HIV vaccine has successfully cleared trials so far, some drugs are used in high-risk groups and patients. Story continues below advertisement Shares of J&J were down 1.3% at $170.14 in ...

(AP Photo/Themba Hadebe) JOHANNESBURG (AP) — Just a week had remained before scientists in South Africa were to begin ...

Roughly a year and a half since the first version of its COVID-19 vaccine went into its first human volunteer, Moderna is beginning the process again — this time with a vaccine for HIV.

Just before a major HIV vaccine trial was to begin, U.S. funding cuts halted South Africa’s BRILLIANT project, threatening ...

Oxford University researchers trial new HIV vaccine This could be a potential breakthrough for the decades-long epidemic. Lead researcher Tomas Hanke joins us to explain how the vaccine works.

Researchers running the mRNA HIV-vaccine trials first took note of the rashes in 2022, shortly after studies began. But as they started to publicly discuss the side effect, and media reports of them ...

A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated. Developed by researchers from the Massachusetts Institute of Technology (MIT) and ...